Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
PGNY · against 1,336 other Healthcare companies
Ranked #489 of 1,337 · scores higher than 63% of peers
Bars: peers in each 10-point band of the valuation score134 peers with a valuation score of 60–69, including PGNY · Click a bar to see the companies
Mainly thanks to its free cash flow yield, earnings yield and EBITDA yield, which are stronger than most Healthcare peers.
| Metric | PGNY | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 1,287 reported | 3.2% | 1.5% | 64% | 30% | |
| EBITDA yieldHigher is better · 1,357 reported | 6.2% | 4.2% | 62% | 50% | |
| Free cash flow yieldHigher is better · 711 reported | 8.0% | -1.0% | 91% | 20% | |
| Book yieldHigher is better · 1,306 reported | 20.3% | 37.9% | 29% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.3B HKD (≈$2.7B) | 99 | 68 | |
| 1 | 1.1B HKD (≈$146M) | 99 | 72 | |
| 1 | 14.2B HKD (≈$1.8B) | 99 | 64 | |
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 489 | 1.1B EUR (≈$1.2B) | 63 | 44 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 489 | 28.7B USD | 63 | 52 |
| 489 | 142.9B INR (≈$1.7B) | 63 | 64 |
| 489 | 116.5B USD | 63 | 57 |
| 489 | 2.2B USD | 63 | 66 |
| 489 | 22.3B SGD (≈$16.9B) | 63 | 57 |
| 489 | 10.4B USD | 63 | 70 |
| 489 | 5.0B SEK (≈$497M) | 63 | 61 |
| 489 | 884M USD | 63 | 75 |